logo
menu
배경이미지
01About us
Spin offHistoryCollaborationCILoacation
02Platforms
Ocular ImplantsMicroarray Patches
03Pipelines
SMO SeriesSMM SeriesSMZ Series
04Facilities
SMO LineSMM LineSites
05Business
Business ModelCDMO Business
06News
NoticeIRPR
07Contact us
call@sminnovation.com
Home    >    Pipelines    >    SMM SeriesSMM Series

SMM

SMM1
SMM2
SMM3
SMM4
SMM1 image 1
SMM1 image 2

SMM1 Information

Indication
Osteoporosis
Active Ingredient
Teriparatide
Administration Site
Transdemal Administration
Competing Products
Forteo / Lilly
Milestones
milestones
* SMM1 launch schedule is subject to change depending on the patent situation in each country
footer-logo
CEO : Jinha Park
Company : SANGMYUNG innovation Co., Ltd.
T : +82 2 3489 6100
Head Office : 2-27, Yeongmun-ro, Cheoin-gu, Yongin-si, Gyeonggi-do, Republic of Korea
Branch Office : 42, Seocho-daero 52-gil, Seocho-gu, Seoul, Republic of Korea
Privacy PolicyCopyright © SANGMYUNG innovation